Aberdeen Group’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $45.8M | Buy |
138,331
+5,485
| +4% | +$1.87M | 0.07% | 228 |
|
|
2025
Q4 | $52.8M | Sell |
132,846
-24,550
| -16% | -$10.9M | 0.08% | 197 |
|
|
2025
Q3 | $71.7M | Sell |
157,396
-61,228
| -28% | -$24.9M | 0.11% | 151 |
|
|
2025
Q2 | $70.4M | Buy |
218,624
+3,239
| +2% | +$896K | 0.12% | 158 |
|
|
2025
Q1 | $57.1M | Buy |
215,385
+24,544
| +13% | +$6.31M | 0.11% | 172 |
|
|
2024
Q4 | $45.2M | Sell |
190,841
-9,228
| -5% | -$2.43M | 0.08% | 222 |
|
|
2024
Q3 | $55M | Buy |
200,069
+91
| +0% | +$23.7K | 0.1% | 201 |
|
|
2024
Q2 | $48.6M | Sell |
199,978
-19,297
| -9% | -$3.05M | 0.09% | 211 |
|
|
2024
Q1 | $32.8M | Sell |
219,275
-13,441
| -6% | -$2.24M | 0.06% | 284 |
|
|
2023
Q4 | $44.5M | Buy |
232,716
+209,691
| +911% | +$35.7M | 0.1% | 225 |
|
|
2023
Q3 | $4.08M | Sell |
23,025
-559
| -2% | -$107K | 0.01% | 596 |
|
|
2023
Q2 | $4.48M | Buy |
23,584
+130
| +0.6% | +$25.8K | 0.01% | 594 |
|
|
2023
Q1 | $4.7M | Buy |
23,454
+10,330
| +79% | +$2.17M | 0.01% | 582 |
|
|
2022
Q4 | $3.12M | Buy |
13,124
+915
| +7% | +$195K | 0.01% | 640 |
|
|
2022
Q3 | $2.44M | Buy |
12,209
+1,408
| +13% | +$269K | 0.01% | 672 |
|
|
2022
Q2 | $1.57M | Sell |
10,801
-222
| -2% | -$31.5K | 0.01% | 740 |
|
|
2022
Q1 | $1.81M | Sell |
11,023
-144
| -1% | -$21.9K | ﹤0.01% | 750 |
|
|
2021
Q4 | $1.89M | Buy |
11,167
+382
| +4% | +$71K | ﹤0.01% | 784 |
|
|
2021
Q3 | $2.04M | Buy |
10,785
+683
| +7% | +$128K | ﹤0.01% | 784 |
|
|
2021
Q2 | $1.71M | Sell |
10,102
-2,043
| -17% | -$299K | ﹤0.01% | 798 |
|
|
2021
Q1 | $1.72M | Buy |
12,145
+260
| +2% | +$39.1K | ﹤0.01% | 790 |
|
|
2020
Q4 | $1.55M | Buy |
11,885
+159
| +1% | +$21.2K | ﹤0.01% | 778 |
|
|
2020
Q3 | $1.71M | Sell |
11,726
-3,016
| -20% | -$429K | ﹤0.01% | 730 |
|
|
2020
Q2 | $2.18M | Buy |
14,742
+363
| +3% | +$48.9K | 0.01% | 687 |
|
|
2020
Q1 | $1.56M | Sell |
14,379
-142
| -1% | -$16.4K | 0.01% | 703 |
|
|
2019
Q4 | $1.67M | Buy |
14,521
+1,126
| +8% | +$112K | ﹤0.01% | 746 |
|
|
2019
Q3 | $1.08M | Buy |
13,395
+533
| +4% | +$42.2K | ﹤0.01% | 793 |
|
|
2019
Q2 | $933K | Buy |
12,862
+1,276
| +11% | +$97.9K | ﹤0.01% | 828 |
|
|
2019
Q1 | $1.08M | Buy |
11,586
+6,793
| +142% | +$568K | ﹤0.01% | 801 |
|
|
2018
Q4 | $329K | Sell |
4,793
-50
| -1% | -$3.85K | ﹤0.01% | 853 |
|
|
2018
Q3 | $424K | Sell |
4,843
-110
| -2% | -$11.1K | ﹤0.01% | 871 |
|
|
2018
Q2 | $488K | Buy |
+4,953
| New | +$491K | ﹤0.01% | 855 |
|
Other funds holding ALNY
VPM
VCM
